期刊文献+

GADD45A基因在人贲门腺癌组织中的异常甲基化和表达及其临床意义 被引量:1

Expression and aberrant methylation of growth arrest and DNA-damage-inducible 45 alpha gene in human gastric cardia adenocarcinoma tissues and its clinical significance
下载PDF
导出
摘要 目的:探讨生长阻滞和DNA损伤诱导45A(growth arrest and DNA-damage-inducible 45 alpha,GADD45A)基因在贲门腺癌(gastric cardia adenocarcinoma,GCA)中的异常甲基化及表达,并探讨其临床意义。方法:选取河北医科大学第四医院2004-2007年期间GCA患者组织标本(138例)。分别应用亚硫酸氢盐测序法(bisulfite sequencing,BS-Seq)、亚硫酸氢盐转换-甲基化特异性聚合酶链式反应(bisulfite conversion-methylation specific polymerase chain reaction,BS-MSP)、RT-PCR和免疫组织化学法检测GADD45A基因在GCA组织及癌旁正常组织中的甲基化、GADD45A mRNA及蛋白表达的情况。结果:GADD45A远端启动子区的4个CpG位点在GCA组织中的甲基化率[44.93%(62/138)]显著高于癌旁正常组织[0.00%(0/138)](P<0.01),且在Ⅲ期和Ⅳ期GCA组织中的甲基化率显著高于Ⅰ期和Ⅱ期GCA组织(P<0.05),但GADD45A在GCA组织中的甲基化与患者的年龄、性别及病理分化程度无关(P>0.05)。GADD45A近端启动子(region 2)及第一外显子区(region 3)的CpG岛在GCA及癌旁组织中均未检测到甲基化。GCA组织中GADD45A mRNA和蛋白阳性表达率显著低于癌旁正常组织[(0.35±0.15)vs(0.78±0.26),42.75%vs 71.01%,均P<0.05],且与其远端启动子区4个CpG位点的甲基化状态之间有明显的相关性(r=-0.52,P<0.01)。结论:GADD45A基因远端启动子区的4个CpG位点的高甲基化导致的基因沉默可能与GCA中GADD45A基因表达降低有关。 Objective:To investigate the expression and aberrant methylation of growth arrest and DNA-damage-inducible 45 alpha(GADD45A) gene in gastric cardia adenocarcinoma(GCA) and to explore its clinical significance.Methods: Tissue samples in GCA patients(138 cases) were selected from Fourth Hospital of Hebei University during 2004 to 2007.Bisulfite sequencing(BS-Seq),bisulfite conversion-methylation specific polymerase chain reaction(BS-MSP),reverse transcription-polymerase chain reaction(RT-PCR) and immunohistochemistry methods were used respectively to detect the methylation status,mRNA and protein expression of GADD45A gene in GCA tissues and the para-carcinoma normal tissues.Results: The methylation frequency of four CpG sites in distal promoter of GADD45A in GCA tissues(44.93%,[62/138]) was significantly higher than that in the para-carcinoma normal tissues(0.00%,0/138)(P0.01).The methylation frequency of 4 CpG sites in stage Ⅲ and Ⅳ GCA tissues was significantly higher than that in stage Ⅰ and Ⅱ GCA tissues(P0.05).However,the methylation status GADD45A in GCA tissues was not correltaed with age,gender and pathological differentiation(P0.05).For GADD45A region 2 and 3 located in proximal promoter and exon 1,no methylation was detected in GCA and the para-carcinoma normal tissues.The expression of GADD45A mRNA and positive expression rate of GADD45A protein in GCA tissues were significantly lower than those in the para-carcinoma normal tissues([0.35±0.15] vs [0.78±0.26],42.75% vs 71.01%,P0.05) and was associated with methylation status of 4 CpG sites in distal promoter(r=-0.52,P0.01).Conclusion: Hypermethylation of four CpG sites in distal promoter of GADD45A gene may be responsible for the decreased expression of GADD45A in GCA.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2013年第3期317-322,共6页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金资助项目(No.81101854) 河北省科技厅资助项目(No.072761223)~~
关键词 贲门腺癌 生长阻滞和DNA损伤诱导45A基因 甲基化 gastric cardia adenocarcinoma(GCA) GADD45A gene methylation
  • 相关文献

参考文献20

  • 1Fomace AJ Jr , Alamo I Jr, Hollander MC. DNA damage?inducible transcripts in mammalian cells [J]. Proc Nat! Acad Sci USA, 1988, 85 (23) : 8800-8804.
  • 2Rosemary Siafakas A, Richardson DR. Growth arrest and DNA damage45 alpha (GADD45alpha) [J]. Int J Biochem Cell Bioi, 2009, 41 (5) : 986-989.
  • 3Cretu A, Sha X, Tront J, et al. Stress sensor Gadd45 genes as therapeutic targets in cancer [J]. Cancer Ther, 2009, 7 ( A) : 268-276.
  • 4Wang W, Huper G, Guo Y, et al. Analysis of methylation-sensi?tive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer [J]. Oncogene, 2005, 24 (16 ): 2705- 2714.
  • 5Ramachandran K, Gopisetty G, Gordian E, et al. Methylation?mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target [J]. Cancer Res, 2009, 69 (4): 1527-1535.
  • 6Higashi H, Vallbohmer D, Wamecke-Eberz U, et al. Down-regu?lation of Gadd45 expression is associated with tumor differentiation in non-small cell lung cancer [J]. Anticancer Res, 2006, 26 (3A) : 2143-2147.
  • 7Wang Bx, Yin BL, He B, et ai, Overexpression of DNA damage?induced 45 (l gene contributes to esophageal squamous cell cancer by promoter hypomethylation [J]. J Exp Clin Cancer Res, 2012, 31: 11.
  • 8Schneider G, Weber A, Zechner U, et al. GADD45alpha is highly expressed in pancreatic ductal adenocarcinoma cells and re?quired for tumor cell viability [J]. Int J Cancer, 2006, 118 (10) : 2405-2411.
  • 9Reddy SP, Britto R, Vinnakota K, et al. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis [J]. Clin Cancer Res, 2008, 14 ( 10) : 2978-2987.
  • 10Yamasawa K, Nio Y, Dong M, et al. Clinicopathological signifi?cance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer [J]. Clin Cancer Res, 2002, 8 (8) : 2563-2569.

二级参考文献13

  • 1DAMMANN R, LI C, YOON JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3[J]. Nat Genet, 2000, 25(3) : 315-319.
  • 2SHIVAKUMAR L, MINNA J, SAKAMAKI T,et al. The RASSF1 A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation[J]. Mol Cell Biol, 2002, 22(12) :4309- 4318.
  • 3HERMAN J G, GRAFF J R, MYOHANEN S, et al. Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands[ J]. Proc Natl Acad Sci USA,1996, 93(18) :9821-9826.
  • 4KHOKHLATCHEV A, RABIZADEH S, XAVIER R, et al. Identification of a novel Ras-regulated proapoptotic pathway [ J ]. Curr Biol,2002, 12 (4) : 253-265.
  • 5DAMMANN R, TAKAHASHI T, PFEIFER GP, et al. The CpG island of the novel tumor suppressor gene RASSF1A is intenselymethylated in primary small cell lung carcinomas [ J]. Orwogene, 2001, 20(27) : 3563-3567.
  • 6AGATHANGGELOU A, HONORIO S, MACARTNEY D P, et al. Methylation associated inactivation of RASSFIA from region 3p21.3 in lung, breast and ovarian tumours [ J]. Oncogene, 2001,20 (12) : 1509-1518.
  • 7LO K W, KWONG J, HUI A B, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma [ J ]. Cancer Res, 2001,61(10) : 3877-3881.
  • 8LI J Y, ERSHOW A G, CHEN Z J, et al. A case-control study of cancer of the esophageal and gastric cardia in Linxian [ J ]. Int J Cancer, 1989, 43 (5) : 755-761.
  • 9ZHANG YJ , AHSAN H , CHEN Y, et al. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin BI2DNA adduct levels in human hepatocellular carcinoma[J]. Mol Carcinog, 2002 , 35 (2) : 85-92.
  • 10BYUN D S, LEE M G, CHAE K S,et al. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma [ J ]. Cancer Res, 2001,61 (19) : 7034-7038.

共引文献8

同被引文献13

  • 1Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy [J]. Science, 2001, 294(5547) : 1704-1708.
  • 2Hanai J, Cao P, Tanksale P, et al. The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity [J]. J Clin Invest, 2007, 117(12) : 3940-3951.
  • 3Stitt TN, Drujan D, Clarke BA, et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors [ J]. Mol Cell, 2004, 14(3) :395-403.
  • 4Tan J, Yang X, Zhuang L, et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells [ J]. Genes Dev, 2007, 21(9) : 1050-1063.
  • 5Qin H, Chan MW, Liyanarachchi S, et al. An integrative ChiP-chip and gene expression profiling to model SMAD regulatory modules [J]. BMC Syst Biol, 2009, 3(1 ) : 73.
  • 6Chou JL, Su HY, Chen LY, et al. Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer [J]. Lab Invest, 2010, 90(3): 414-425.
  • 7Sasaki M, Anast J, Bassett W, et al. Bisulfite conversion-specific and methylation-specific PCR: A sensitive technique for accurate evaluation of CpG methylation [J]. Biochem Biophys Res Commnn, 2003, 309(2): 305-309.
  • 8Li HH, Kedar V, Zhang C, et al. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex [J~. J Clin Invest, 2004, 114(8); 1058-1071.
  • 9Li J J, Zhang TP, Meng Y, et al. Stability of F-box protein atrogin-1 is regulated by p38 mitogen-activated protein kinase pathway in cardiac H9c2 ceils [J]. Cell Physiol Biochem, 2011, 27(5) : 463-470.
  • 10Gomes MD, Lecker SH, Jagoe RT, et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy [J]. Proc Natl Acad Sci U S A, 2001, 98(25): 14440-14445.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部